Evotec Announces CEO Transition

Rhea-AI Summary

Evotec SE (EVT) announces CEO Dr. Werner Lanthaler's resignation for personal reasons. Dr. Mario Polywka to serve as interim CEO. The company confirms its 2023 guidance.

HAMBURG, GERMANY / ACCESSWIRE / January 3, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that CEO Dr Werner Lanthaler has informed the company, that he has decided to step down as CEO and will not continue to serve until the end of his current term, for personal reasons. The Supervisory Board has accepted his resignation from his office.

Werner Lanthaler will continue to be available as a strategic advisor to the company's Supervisory Board. Dr Mario Polywka, former COO and currently member of the Supervisory Board has agreed to step in as interim CEO.

Evotec confirms guidance 2023.

- End of the ad hoc release -

Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 19405058, volker.braun@evotec.com

SOURCE: Evotec SE

View the original press release on accesswire.com

FAQ

Who is stepping down as CEO of Evotec SE (EVT)?

CEO Dr. Werner Lanthaler has decided to step down for personal reasons.

Who will serve as the interim CEO of Evotec SE (EVT)?

Dr. Mario Polywka, former COO and current member of the Supervisory Board, has agreed to step in as interim CEO.

What guidance has Evotec SE (EVT) confirmed for 2023?

Evotec SE (EVT) has confirmed its guidance for 2023.

What is the contact information for Evotec SE (EVT)?

Contact Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 19405058, volker.braun@evotec.com